Ligand validation:7BO3

MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7BO3_MES_A_604	23%	9%	0.219	0.839	2.18	2.34	1	6	2	0	100%	0.778
7BO4_MES_A_602	47%	11%	0.159	0.896	2.05	2.19	1	8	2	0	100%	0.743
1P0M_MES_A_606	31%	29%	0.187	0.856	1.55	1.28	2	1	6	0	100%	0.6667
8QTW_MES_A_604	30%	10%	0.136	0.798	2.02	2.25	1	6	2	0	100%	1
7ZPB_MES_A_606	27%	10%	0.253	0.902	2.03	2.31	1	7	1	0	100%	1
7QHE_MES_A_605	26%	9%	0.198	0.836	1.97	2.54	1	6	4	0	100%	1
2IUY_MES_B_1355	100%	9%	0.026	0.997	1.73	2.73	1	7	0	0	100%	1
3DPJ_MES_A_192	100%	8%	0.022	0.995	2.2	2.41	1	6	3	0	100%	1
5A0C_MES_B_1002	100%	11%	0.033	0.993	1.84	2.39	3	3	0	0	100%	1
8AJQ_MES_H_201	100%	38%	0.037	0.992	1.52	0.93	1	1	0	0	100%	1
5APG_MES_A_1187	100%	12%	0.044	0.99	1.48	2.57	3	6	0	0	100%	0.9292

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.